Overcoming Challenges with Viral Vector Optimization for Hemophilia Gene Therapy

Mirus Podcast Graphic Thumbnail

In this podcast, listen to the first-hand account of how researchers from St. Jude overcame the challenges with viral vector optimization to produce ground-breaking gene therapy for hemophilia with the hope to start treating patients on a large-scale in 2023.

Please complete the form below to access this podcast. Thank you for your interest!

First Name:

Last Name:

Institution/Company:

Institution Type:

Country:

Email:

I consent to receive newsletters and emails from Mirus Bio. For further information, please consult the Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Google Terms of Service apply.

Like this paper? We have more content like it!

Visit our blog: The TransMission

Or, sign up for our Transfection Connection newsletter below!

Overcoming Challenges with Viral Vector Optimization for Hemophilia Gene Therapy

Please Wait...